Back

Immune cell signature in non-ischemic heart failure indicates chronic activation and immunosenescence

20 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Advances in mechanisms of heart failure Pathophysiology and Mechanisms HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Lukas Baumhove

University Medical Centre Groningen, Groningen (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure
Doctor N. De Biase (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
Miss J. Zhang (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Inositol 1,4,5-trisphosphate receptors (ITP3Rs) ablation reduces the expression of chemokine ligands and pro-inflammatory interleukins
Doctor U. Kansakar (Bronx, US)
Abstract Slides Video
Presentation thumbnail
The role of EDEM2 in the heart under metabolic stress
Miss O. Fonseka (Manchester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in mechanisms of heart failure

The Event

Event poster

Heart Failure 2025

20 May 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Targeting monocytes in heart failure
thumbnail
Congress Presentation
Increased CD4+ T lymphocyte count is associated with mortality in patients with heart failure and type 2 cardiorenal syndrome
thumbnail
Congress Presentation
T cell therapeutic targets in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources